SCHEDULE 13G Filed 2026-10-16 Event — SEC 0001104659-26-116496 →

Coastlands Capital LP → Frazier Life Sciences Acquisition Corp. II FLSC

Stake: — Shares: — Class: Class A Ordinary Shares, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other Filings by Coastlands Capital LP

Filed	Form	Issuer	Stake	Shares
2026-10-14	SCHEDULE 13G	iBio, Inc.	—	—	view →
2026-10-07	SCHEDULE 13G	OnKure Therapeutics, Inc.	—	—	view →
2026-10-05	SCHEDULE 13G	Pyxis Oncology, Inc.	—	—	view →
2026-07-01	SCHEDULE 13G/A	Pasithea Therapeutics Corp. KTTAW	—	—	view →
2026-07-01	SCHEDULE 13G/A	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-06-24	SCHEDULE 13G	Adial Pharmaceuticals, Inc. ADIL	—	—	view →
2026-06-17	SCHEDULE 13G	Eloxx Pharmaceuticals, Inc. ELOX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →